Immunoadsorption and covid 19 pandemic

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), responsible for the coronavirus disease 2019 (COVID-19) pandemic has affected millions of people worldwide. The majority of individuals remain asymptomatic or present with mild symptoms; however nearly 5% of the patients develop severe disease, which is characterized by acute respiratory distress syndrome (ARDS) and multiple-organ failure (MOF) with poor outcomes [1].The basic pathophysiologic mechanism that leads to ARDS and MOF is the exaggerated cytokine release, known as cytokine release syndrome (CRS), or cytokine storm.